Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

525
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
525
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

51
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
51
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

45
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
45
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bench evidence, bedside uncertainty: hyperoxia, mechanical ventilation and lung injury.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Plasma heparan sulfate structural variation and phenotypic heterogeneity in pediatric Acute Respiratory Distress Syndrome.

Scientific reports·2026
Same author

Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell Disease.

Blood·2026
Same author

Comparative Effectiveness of Single Versus Bilateral Lung Transplantation in Dually Listed Recipients: A National Target Trial.

Annals of surgery·2026
Same author

Plasma Heparan Sulfate Structural Variation and Phenotypic Heterogeneity in Pediatric Acute Respiratory Distress Syndrome.

Research square·2026
Same author

The four voltage-sensing domains of T-type calcium channels activate near the resting membrane potential.

Nature communications·2026

Related Experiment Video

Updated: Sep 27, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K

Cell saver blood transfusions may be associated with a decrease in inflammation and improved outcome measures in

Michael J Martinez1, Andreas Schwingshackl1, Tahmineh Romero2

  • 1Division of Critical Care Medicine, Department of Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, CA, USA.

Perfusion
|April 12, 2022
PubMed
Summary

Intraoperative cell saver (CS) transfusions in children undergoing open-heart surgery may reduce the inflammatory response and improve outcomes. This study found CS blood transfusions were associated with better renal and pulmonary function post-surgery.

Keywords:
Cardiopulmonary bypassblood transfusioncytokinesinflammationoperative blood salvagepediatrics

More Related Videos

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.1K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K

Related Experiment Videos

Last Updated: Sep 27, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K
Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.1K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Transfusion Medicine

Background:

  • Cardiopulmonary bypass (CPB) for congenital heart disease surgery triggers systemic inflammation, potentially causing acute lung and kidney injury.
  • Blood transfusions during CPB can worsen inflammation, increasing patient morbidity and mortality.

Purpose of the Study:

  • To investigate if intraoperative cell saver (CS) blood transfusions attenuate the proinflammatory cytokine response after CPB, compared to standard red blood cell transfusions.
  • To evaluate the impact of CS transfusions on clinical outcomes, including renal function, pulmonary function, and length of hospital stay.

Main Methods:

  • Serum cytokine levels (IL-10, IL-1RA, IL-6, IL-8, TNF-α) were measured preoperatively and on postoperative days 0, 1, and 2.
  • Clinical parameters including blood urea nitrogen (BUN), creatinine, milrinone use, extubation time, and hospital length of stay were assessed.

Main Results:

  • The CS group showed significantly lower anti-inflammatory IL-10 levels on postoperative day 0 compared to the control group.
  • Patients receiving CS transfusions had significantly lower BUN and creatinine levels on postoperative day 2.
  • The CS group experienced reduced milrinone use, shorter extubation times, and a decreased hospital length of stay.

Conclusions:

  • Intraoperative cell saver transfusions in pediatric patients may reduce the postoperative inflammatory response.
  • CS transfusions are associated with improved renal and pulmonary function after CPB surgery.
  • CS transfusions may lead to better clinical outcomes, including shorter hospital stays.